Bunzl plc (BZLFY)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,665	13,574	13,642	11,164	13,065	11,127
Market Cap Growth	-0.50%	-0.50%	22.20%	-14.55%	17.41%	21.78%
Enterprise Value	12,813	16,206	15,751	13,421	15,361	13,431
Last Close Price	15.03	20.33	19.63	15.55	18.37	15.38
PE Ratio	15.43	21.67	20.35	19.53	21.79	18.95
PS Ratio	0.66	0.92	0.91	0.77	0.94	0.81
PB Ratio	2.77	3.89	3.61	3.41	4.38	4.25
P/FCF Ratio	8.87	12.45	12.44	10.11	13.62	10.64
P/OCF Ratio	8.48	11.90	11.85	9.74	13.16	10.31
EV/Sales Ratio	0.82	1.10	1.05	0.93	1.10	0.97
EV/EBITDA Ratio	8.09	12.82	12.65	12.17	14.56	12.22
EV/EBIT Ratio	11.74	15.71	15.26	14.71	17.60	14.51
EV/FCF Ratio	11.76	14.87	14.36	12.15	16.02	12.85
Debt / Equity Ratio	1.36	1.36	1.07	1.19	1.19	1.41
Debt / EBITDA Ratio	3.18	3.18	2.77	3.03	2.86	2.88
Debt / FCF Ratio	4.37	4.37	3.68	3.52	3.69	3.54
Asset Turnover	1.29	1.29	1.36	1.53	1.48	1.59
Inventory Turnover	4.96	4.96	5.11	5.60	5.34	5.77
Quick Ratio	0.72	0.72	0.89	0.86	0.77	0.85
Current Ratio	1.18	1.18	1.40	1.40	1.34	1.42
Return on Equity (ROE)	17.41%	17.41%	18.50%	19.27%	21.48%	23.47%
Return on Assets (ROA)	5.63%	5.63%	5.82%	6.00%	5.78%	6.65%
Return on Capital (ROIC)	8.09%	8.09%	8.39%	8.79%	8.53%	9.72%
Return on Capital Employed (ROCE)	15.30%	15.30%	14.90%	14.60%	14.90%	16.30%
Earnings Yield	6.48%	4.61%	4.91%	5.12%	4.59%	5.28%
FCF Yield	11.28%	8.03%	8.04%	9.90%	7.34%	9.40%
Dividend Yield	3.08%	4.55%	4.43%	4.86%	4.20%	4.80%
Payout Ratio	45.68%	45.68%	39.85%	40.16%	40.74%	39.88%
Buyback Yield / Dilution	0.21%	0.21%	-0.09%	-0.36%	-0.27%	-0.24%
Total Shareholder Return	3.29%	4.76%	4.34%	4.50%	3.93%	4.56%

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.